Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of patient-reported experiences up to 2 years after receiving idecabtagene vicleucel (ide-cel, bb2121) for relapsed or refractory multiple myeloma: Longitudinal findings from the phase 2 KarMMa trial.
Delforge M, Otero PR, Shah N, Moshkovich O, Braverman J, Dhanda DS, Lanar S, Devlen J, Miera M, Gerould H, Campbell TB, Munshi NC. Delforge M, et al. Among authors: moshkovich o. Leuk Res. 2023 Jun;129:107074. doi: 10.1016/j.leukres.2023.107074. Epub 2023 Apr 3. Leuk Res. 2023. PMID: 37087950 Free article. Clinical Trial.
Patient experience before and after treatment with idecabtagene vicleucel (ide-cel, bb2121): qualitative analysis of patient interviews in the KarMMa trial.
Shah N, Delforge M, San-Miguel J, Moshkovich O, Braverman J, Dhanda DS, Lanar S, Miera M, Williams A, Murphy R, Devlen J, Hege K, Campbell TB, Munshi NC. Shah N, et al. Among authors: moshkovich o. Leuk Res. 2022 Sep;120:106921. doi: 10.1016/j.leukres.2022.106921. Epub 2022 Jul 21. Leuk Res. 2022. PMID: 35930999 Free article.
Experiences of children and adolescents living with achondroplasia and their caregivers.
Shediac R, Moshkovich O, Gerould H, Ballinger R, Williams A, Bellenger MA, Quinn J, Hoover-Fong J, Mohnike K, Savarirayan R, Kelly D. Shediac R, et al. Among authors: moshkovich o. Mol Genet Genomic Med. 2022 Apr;10(4):e1891. doi: 10.1002/mgg3.1891. Epub 2022 Feb 9. Mol Genet Genomic Med. 2022. PMID: 35138050 Free PMC article.
Symptom assessment in hypereosinophilic syndrome: Toward development of a patient-reported outcomes tool.
Kovacs N, Benjamin K, Holland-Thomas N, Moshkovich O, Nelsen LM, Ortega H, Schwartz EJ, Steinfeld J, Kirby SY, Klion A, Khoury P. Kovacs N, et al. Among authors: moshkovich o. J Allergy Clin Immunol Pract. 2020 Oct;8(9):3209-3212.e8. doi: 10.1016/j.jaip.2020.04.069. Epub 2020 May 15. J Allergy Clin Immunol Pract. 2020. PMID: 32416262 Free PMC article. No abstract available.
12 results